title: Some aspects of treatment and habilitation of children and adolescents with autistic disorder in Northern-Finland.
abstract: Hospital records and data on the treatment/habilitation status of 187 children with autism aged 3-18 years were gathered from Northern Finland. The treatment programs and therapies varied, depending on the trained staff available. One-hundred and fifty-two (82.9%) children and adolescents with autism received more than one therapeutic intervention or specific training program. The most common therapies were physiotherapy as well as speech, occupational and music therapy. 43.9% of the children and adolescents with autism received specific training according to TEACCH (Treatment and Education of Autistic and related Communication-Handicapped Children), 10.2% according to Lovaas and 30.5% according to the Portage program. Antiepileptic medication had been prescribed to 23.9% and psychopharmacological interventions to 14.9% of the individuals with autistic disorder (AD). One hundred and seventy-eight subjects out of 187 showed some improvement on the Childhood Autism Rating Scale (CARS), even if no statistically significant difference was found between the outcome of the available habilitation methods.
authors.affiliation: Clinic of Child Psychiatry, University Hospital of Oulu, Oulu, Finland. marko.kielinen@autismiliitto.fi
authors.forename: Marko
authors.initials: M
authors.lastname: Kielinen
authors.forename: Sirkka-Liisa
authors.initials: SL
authors.lastname: Linna
authors.forename: Irma
authors.initials: I
authors.lastname: Moilanen
mesh_terms: D000293:Adolescent; D000927:Anticonvulsants / Q000627:therapeutic use; D001321:Autistic Disorder / Q000145:classification / Q000150:complications / Q000188:drug therapy / Q000534:rehabilitation* / Q000628:therapy*; D002648:Child; D002675:Child, Preschool; D004827:Epilepsy / Q000150:complications / Q000188:drug therapy; D005260:Female; D005387:Finland; D006801:Humans; D008297:Male; D010353:Patient Education as Topic; D010465:Perception; D016896:Treatment Outcome
chemical_list: D000927:Anticonvulsants